{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:22:55Z","timestamp":1790281375522,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:00:00Z","timestamp":1258588800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T00:00:00Z","timestamp":1258588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1038\/leu.2009.233","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T16:29:12Z","timestamp":1258648152000},"page":"115-124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Cathepsin B release after imatinib-mediated lysosomal membrane permeabilization triggers BCR\u2013ABL cleavage and elimination of chronic myelogenous leukemia cells"],"prefix":"10.1038","volume":"24","author":[{"given":"A","family":"Puissant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Colosetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Cassuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Raynaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Auberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,11,19]]},"reference":[{"key":"BFleu2009233_CR1","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/306239a0","volume":"306","author":"N Heisterkamp","year":"1983","unstructured":"Heisterkamp N, Stephenson JR, Groffen J, Hansen PF, de Klein A, Bartram CR et al. Localization of the c-ab1 oncogene adjacent to a translocation break point in chronic myelocytic leukaemia. Nature 1983; 306: 239\u2013242.","journal-title":"Nature"},{"key":"BFleu2009233_CR2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0092-8674(84)90077-1","volume":"36","author":"J Groffen","year":"1984","unstructured":"Groffen J, Stephenson JR, Heisterkamp N, de Klein A, Bartram CR, Grosveld G . Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93\u201399.","journal-title":"Cell"},{"key":"BFleu2009233_CR3","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV . The molecular biology of chronic myeloid leukemia. Blood 2000; 96: 3343\u20133356.","journal-title":"Blood"},{"key":"BFleu2009233_CR4","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/sj.leu.2403241","volume":"18","author":"LS Steelman","year":"2004","unstructured":"Steelman LS, Pohnert SC, Shelton JG, Franklin RA, Bertrand FE, McCubrey JA . JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 2004; 18: 189\u2013218.","journal-title":"Leukemia"},{"key":"BFleu2009233_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/sj.cdd.4400400","volume":"5","author":"S Dan","year":"1998","unstructured":"Dan S, Naito M, Tsuruo T . Selective induction of apoptosis in Philadelphia chromosome-positive chronic myelogenous leukemia cells by an inhibitor of BCR - ABL tyrosine kinase, CGP 57148. Cell Death Differ 1998; 5: 710\u2013715.","journal-title":"Cell Death Differ"},{"key":"BFleu2009233_CR6","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1182\/blood.V96.6.2246","volume":"96","author":"G Fang","year":"2000","unstructured":"Fang G, Kim CN, Perkins CL, Ramadevi N, Winton E, Wittmann S et al. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes Bcr-Abl-positive human leukemia cells to apoptosis due to antileukemic drugs. Blood 2000; 96: 2246\u20132253.","journal-title":"Blood"},{"key":"BFleu2009233_CR7","doi-asserted-by":"publisher","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","volume":"22","author":"F Luciano","year":"2003","unstructured":"Luciano F, Jacquel A, Colosetti P, Herrant M, Cagnol S, Pages G et al. Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function. Oncogene 2003; 22: 6785\u20136793.","journal-title":"Oncogene"},{"key":"BFleu2009233_CR8","doi-asserted-by":"publisher","first-page":"14907","DOI":"10.1073\/pnas.0606176103","volume":"103","author":"J Kuroda","year":"2006","unstructured":"Kuroda J, Puthalakath H, Cragg MS, Kelly PN, Bouillet P, Huang DC et al. Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 2006; 103: 14907\u201314912.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009233_CR9","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1182\/blood-2003-05-1605","volume":"103","author":"M Okada","year":"2004","unstructured":"Okada M, Adachi S, Imai T, Watanabe K, Toyokuni SY, Ueno M et al. A novel mechanism for imatinib mesylate-induced cell death of BCR-ABL-positive human leukemic cells: caspase-independent, necrosis-like programmed cell death mediated by serine protease activity. Blood 2004; 103: 2299\u20132307.","journal-title":"Blood"},{"key":"BFleu2009233_CR10","doi-asserted-by":"publisher","first-page":"2445","DOI":"10.1038\/sj.onc.1210034","volume":"26","author":"A Jacquel","year":"2007","unstructured":"Jacquel A, Colosetti P, Grosso S, Belhacene N, Puissant A, Marchetti S et al. Apoptosis and erythroid differentiation triggered by Bcr-Abl inhibitors in CML cell lines are fully distinguishable processes that exhibit different sensitivity to caspase inhibition. Oncogene 2007; 26: 2445\u20132458.","journal-title":"Oncogene"},{"key":"BFleu2009233_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/nature05293","volume":"443","author":"DE Bredesen","year":"2006","unstructured":"Bredesen DE, Rao RV, Mehlen P . Cell death in the nervous system. Nature 2006; 443: 796\u2013802.","journal-title":"Nature"},{"key":"BFleu2009233_CR12","doi-asserted-by":"publisher","first-page":"E255","DOI":"10.1038\/ncb1101-e255","volume":"3","author":"KF Ferri","year":"2001","unstructured":"Ferri KF, Kroemer G . Organelle-specific initiation of cell death pathways. Nat Cell Biol 2001; 3: E255\u2013E263.","journal-title":"Nat Cell Biol"},{"key":"BFleu2009233_CR13","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/nrc1738","volume":"5","author":"G Kroemer","year":"2005","unstructured":"Kroemer G, Jaattela M . Lysosomes and autophagy in cell death control. Nat Rev Cancer 2005; 5: 886\u2013897.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2009233_CR14","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1074\/jbc.M308347200","volume":"279","author":"T Cirman","year":"2004","unstructured":"Cirman T, Oresic K, Mazovec GD, Turk V, Reed JC, Myers RM et al. Selective disruption of lysosomes in HeLa cells triggers apoptosis mediated by cleavage of Bid by multiple papain-like lysosomal cathepsins. J Biol Chem 2004; 279: 3578\u20133587.","journal-title":"J Biol Chem"},{"key":"BFleu2009233_CR15","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1084\/jem.20021952","volume":"197","author":"P Boya","year":"2003","unstructured":"Boya P, Andreau K, Poncet D, Zamzami N, Perfettini JL, Metivier D et al. Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med 2003; 197: 1323\u20131334.","journal-title":"J Exp Med"},{"key":"BFleu2009233_CR16","doi-asserted-by":"publisher","first-page":"19140","DOI":"10.1074\/jbc.M802513200","volume":"283","author":"G Droga-Mazovec","year":"2008","unstructured":"Droga-Mazovec G, Bojic L, Petelin A, Ivanova S, Romih R, Repnik U et al. Cysteine cathepsins trigger caspase-dependent cell death through cleavage of bid and antiapoptotic Bcl-2 homologues. J Biol Chem 2008; 283: 19140\u201319150.","journal-title":"J Biol Chem"},{"key":"BFleu2009233_CR17","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/cdd.2008.107","volume":"15","author":"Y Kamitsuji","year":"2008","unstructured":"Kamitsuji Y, Kuroda J, Kimura S, Toyokuni S, Watanabe K, Ashihara E et al. The Bcr-Abl kinase inhibitor INNO-406 induces autophagy and different modes of cell death execution in Bcr-Abl-positive leukemias. Cell Death Differ 2008; 15: 1712\u20131722.","journal-title":"Cell Death Differ"},{"key":"BFleu2009233_CR18","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1182\/blood.V96.3.1070","volume":"96","author":"FX Mahon","year":"2000","unstructured":"Mahon FX, Deininger MW, Schultheis B, Chabrol J, Reiffers J, Goldman JM et al. Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance. Blood 2000; 96: 1070\u20131079.","journal-title":"Blood"},{"key":"BFleu2009233_CR19","doi-asserted-by":"publisher","first-page":"7863","DOI":"10.1038\/sj.onc.1208069","volume":"23","author":"M Herrant","year":"2004","unstructured":"Herrant M, Jacquel A, Marchetti S, Belhacene N, Colosetti P, Luciano F et al. Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis. Oncogene 2004; 23: 7863\u20137873.","journal-title":"Oncogene"},{"key":"BFleu2009233_CR20","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1096\/fj.03-0322","volume":"17","author":"A Jacquel","year":"2003","unstructured":"Jacquel A, Herrant M, Legros L, Belhacene N, Luciano F, Pages G et al. Imatinib induces mitochondria-dependent apoptosis of the Bcr-Abl-positive K562 cell line and its differentiation toward the erythroid lineage. Faseb J 2003; 17: 2160\u20132162.","journal-title":"Faseb J"},{"key":"BFleu2009233_CR21","first-page":"5","volume":"5","author":"A Puissant","year":"2008","unstructured":"Puissant A, Grosso S, Jacquel A, Belhacene N, Colosetti P, Cassuto JP et al. Imatinib mesylate-resistant human chronic myelogenous leukemia cell lines exhibit high sensitivity to the phytoalexin resveratrol. Faseb J 2008; 5: 5.","journal-title":"Faseb J"},{"key":"BFleu2009233_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/jcp.10426","volume":"198","author":"K Kohmura","year":"2004","unstructured":"Kohmura K, Miyakawa Y, Kawai Y, Ikeda Y, Kizaki M . Different roles of p38 MAPK and ERK in STI571-induced multi-lineage differentiation of K562 cells. J Cell Physiol 2004; 198: 370\u2013376.","journal-title":"J Cell Physiol"},{"key":"BFleu2009233_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1023\/B:MCBI.0000012830.96393.b9","volume":"258","author":"T Kawano","year":"2004","unstructured":"Kawano T, Horiguchi-Yamada J, Iwase S, Furukawa Y, Kano Y, Yamada H . Inactivation of ERK accelerates erythroid differentiation of K562 cells induced by herbimycin A and STI571 while activation of MEK1 interferes with it. Mol Cell Biochem 2004; 258: 25\u201333.","journal-title":"Mol Cell Biochem"},{"key":"BFleu2009233_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/sj.leu.2403999","volume":"20","author":"J Rangatia","year":"2006","unstructured":"Rangatia J, Bonnet D . Transient or long-term silencing of BCR-ABL alone induces cell cycle and proliferation arrest, apoptosis and differentiation. Leukemia 2006; 20: 68\u201376.","journal-title":"Leukemia"},{"key":"BFleu2009233_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1038\/nrc1949","volume":"6","author":"MM Mohamed","year":"2006","unstructured":"Mohamed MM, Sloane BF . Cysteine cathepsins: multifunctional enzymes in cancer. Nat Rev Cancer 2006; 6: 764\u2013775.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2009233_CR26","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/sj.leu.2404606","volume":"21","author":"A Ertmer","year":"2007","unstructured":"Ertmer A, Huber V, Gilch S, Yoshimori T, Erfle V, Duyster J et al. The anticancer drug imatinib induces cellular autophagy. Leukemia 2007; 21: 936\u2013942.","journal-title":"Leukemia"},{"key":"BFleu2009233_CR27","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI35660","volume":"119","author":"C Bellodi","year":"2009","unstructured":"Bellodi C, Lidonnici MR, Hamilton A, Helgason GV, Soliera AR, Ronchetti M et al. Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells. J Clin Invest 2009; 119: 1109\u20131123.","journal-title":"J Clin Invest"},{"key":"BFleu2009233_CR28","doi-asserted-by":"crossref","unstructured":"Stoka V, Turk B, Schendel SL, Kim TH, Cirman T, Snipas SJ et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. 2001; 276: 3149\u20133157.","DOI":"10.1074\/jbc.M008944200"},{"key":"BFleu2009233_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.4161\/auto.1.2.1697","volume":"1","author":"I Tanida","year":"2005","unstructured":"Tanida I, Minematsu-Ikeguchi N, Ueno T, Kominami E . Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy 2005; 1: 84\u201391.","journal-title":"Autophagy"},{"key":"BFleu2009233_CR30","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1128\/MCB.23.8.2790-2799.2003","volume":"23","author":"D Barila","year":"2003","unstructured":"Barila D, Rufini A, Condo I, Ventura N, Dorey K, Superti-Furga G et al. Caspase-dependent cleavage of c-Abl contributes to apoptosis. Mol Cell Biol 2003; 23: 2790\u20132799.","journal-title":"Mol Cell Biol"},{"key":"BFleu2009233_CR31","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/jnci\/djk004","volume":"99","author":"S Kitareewan","year":"2007","unstructured":"Kitareewan S, Roebuck BD, Demidenko E, Sloboda RD, Dmitrovsky E . Lysosomes and trivalent arsenic treatment in acute promyelocytic leukemia. J Natl Cancer Inst 2007; 99: 41\u201352.","journal-title":"J Natl Cancer Inst"},{"key":"BFleu2009233_CR32","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1073\/pnas.0408592102","volume":"102","author":"H Erdal","year":"2005","unstructured":"Erdal H, Berndtsson M, Castro J, Brunk U, Shoshan MC, Linder S . Induction of lysosomal membrane permeabilization by compounds that activate p53-independent apoptosis. Proc Natl Acad Sci USA 2005; 102: 192\u2013197.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2009233_CR33","first-page":"2143","volume":"119","author":"A Ivanov","year":"2009","unstructured":"Ivanov A, Beers SA, Walshe CA, Honeychurch J, Alduaij W, Cox KL et al. Monoclonal antibodies directed to CD20 and HLA-DR can elicit homotypic adhesion followed by lysosome-mediated cell death in human lymphoma and leukemia cells. J Clin Invest 2009; 119: 2143\u20132159.","journal-title":"J Clin Invest"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2009233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009233","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2009233.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T12:14:58Z","timestamp":1648728898000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2009233"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,19]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["BFleu2009233"],"URL":"https:\/\/doi.org\/10.1038\/leu.2009.233","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11,19]]},"assertion":[{"value":"27 July 2009","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}